Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study explores the relationship between childhood maltreatment experiences and spectral power in high-frequency EEG activity during sleep in a sample of adults experiencing primary
insomnia
. Forty-five nontreated patients with primary
insomnia
spent three consecutive nights in the sleep laboratory, during which polysomnographic recordings were carried out. Nonrapid eye movement and rapid eye movement EEG data were analyzed using spectral analysis. In addition, each participant completed several self-report questionnaires assessing maltreatment in childhood and adolescence, current level of stress, and current depressivity.
Insomnia
patients with self-reported history of moderate to severe childhood maltreatment (
MAL
group; n = 25), as measured by the Childhood Trauma Questionnaire, were compared with
insomnia
patients without such a history (non-
MAL
group; n = 20). The
MAL
group exhibited more absolute and relative beta 1 and beta 2 power in nonrapid eye movement sleep and more absolute beta 1 and beta 2 activity in rapid eye movement sleep than the non-
MAL
group. Contrary to hypothesis, no group differences were found in gamma frequency band. The results suggest an association between history of childhood maltreatment and increased beta EEG activity particularly during nonrapid eye movement sleep in adult
insomnia
, what may reflect heightened psychophysiologic arousal during sleep.
...
PMID:Heightened beta EEG activity during nonrapid eye movement sleep in primary insomnia patients with reports of childhood maltreatment. 2354 70